newsfilter
← Latest News
PR Newswire·

Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain

Brixton Biosciences, a spin-out from Massachusetts General Brigham and a clinical stage life sciences company developing novel therapies for chronic...